Independence Blue Cross and Jefferson health published a study detailing the impact of such care.
Independence Blue Cross and Jefferson Health published a study detailing the impact of supportive oncology programs on patients.1 These programs focus on social work, nutritional counseling, financial advocacy, palliative medicine and pain management. Appearing in the journal Cancer, the study details the positive results that these programs can have for patients.
According to the study, patients in these programs visited the emergency less often, had fewer hospital admissions, and often faced lower costs for care.
In a press release, study co-author and Independence Blue Cross’ director of health informatics and advanced analytics Aaron Smith-Mclallen, PhD, said, “Supportive oncology programs are an enormous resource for our members, and the data show how care utilization patterns change in a positive way for those in need of these supportive services. My hope is that others in the health care field are encouraged by our work and make it a priority to explore these types of programs. Bridging the gap in resources and expertise can help ensure that everyone benefits from the life-enhancing services that supportive oncology programs can provide."
Associated professor of medicine and enterprise director of supportive oncology at Jefferson Health Brooke Worster, MD, FACP, added, “Our study demonstrates that supportive oncology programs not only enhance patient care but also lead to more efficient healthcare utilization and lower costs. These findings underscore the importance of integrating comprehensive support services into standard cancer treatment, potentially transforming the landscape of advanced cancer care.This can only be accomplished on a large scale if both payors and healthcare institutions collaborate as we are happy to have done with IBX on this work.”
Independence Blue Cross also recently announced in July that it had been named the official jersey patch partner for the Philadelphia Phillies baseball team.2
In a press release, Independence Blue Cross president and CEO Gregory E. Deavens said, “The Philadelphia Phillies bring Greater Philadelphia together, and from fans in the stands to stars on the field, wearing a Phillies jersey shows a love of the game and pride in our region. IBX is proud to have our brand cemented in Phillies history, and we are excited for the new opportunities that this expanded partnership brings for our members, our customers, and the communities we serve."
Philies managing partner and CEO John Middleton added, “The Phillies were determined from the start to find the right pinnacle partner for our coveted jersey patch. Independence Blue Cross has been stitched into the fabric of our community for more than 85 years and is as much of a hometown team as the Philadelphia Phillies. We are excited to celebrate IBX, an invaluable partner for nearly four decades, as our inaugural jersey patch sponsor."
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.